Current data, validated through multidimensional analysis, indicate that the core target of miR-15a-5p is IGF1R; CF mutation can influence the PI3K/AKT pathway mediated by IGF1R; and cascade disruption (CKO mice) can terminate the fibrotic process. Here, AKT1 is linked to cystic fibrosis.